| Literature DB >> 35540011 |
Maciej Dobrzynski1, Celina Pezowicz2, Magdalena Tomanik2, Piotr Kuropka3, Krzysztof Dudek4, Katarzyna Fita1, Marzena Styczynska5, Rafal J Wiglusz6.
Abstract
This paper discusses the problems connected with the influence of TCDD on the mechanical properties and structure of the bone tissue in female rats treated with the dioxin. Moreover an analysis of the protective role of tocopherol, acetylsalicylic acid, dexamethazone and levamisol was performed. Rat tibiae were assessed by mechanical testing, and histological and trace element analysis. It was proved that TCDD has negative effect on bone mechanical properties, histological microstructure and trace element content. The results indicate that usage of both steroid and non-steroid anti-inflammatory medicaments, along with tocopherol and levamisol, modulating their activity, can reduce the negative effect of dioxin activity on the bone tissue of female rats intoxicated with TCDD. This journal is © The Royal Society of Chemistry.Entities:
Year: 2018 PMID: 35540011 PMCID: PMC9083442 DOI: 10.1039/c8ra03619e
Source DB: PubMed Journal: RSC Adv ISSN: 2046-2069 Impact factor: 4.036
Fig. 1Measuring setup for three-point bending of tibiae.
Fig. 2(a) 3D-rendering and cross-sections of a rat tibiae before the mechanical investigation (control group) (b) cross-section of the bone used for I calculation; the place of failure marked with an arrow.
Values of the bending strength, Young E modulus and degree of bone mineralization BMD obtained for the research groups under analysisa
| Sample size | BS [MPa] Me ( | E [GPa] Me ( | BMD [g cm−3] Me ( | |
|---|---|---|---|---|
| K | 8 | 348 (267; 427) | 22 (17; 23) | 1.18 (1.14; 1.24) |
| TCDD | 6 | 551 (506; 600)* | 41 (35; 47) | 1.40 (1.38; 1.42)* |
| LEV | 5 | 421 (334; 510) | 31 (19; 36) | 1.25 (1.17; 1.28) |
| E | 5 | 498 (475; 582) | 34 (22; 42) | 1.37 (1.37; 1.45)* |
| DEX | 6 | 403 (285; 625) | 29 (21; 32) | 1.42 (1.35; 1.51)* |
| ASA | 6 | 491 (469; 508) | 26 (22; 42) | 1.25 (1.17; 1.28) |
| ASA + E | 4 | 484 (435; 509) | 43 (31; 48) | 1.39 (1.31; 1.43) |
n – sample size, Me – median, Q1 – lower quartyl (25th percentyl), Q3 – upper quartyl (75th percentyl), *p < 0.05 as compared with the control.
Fig. 3A diagram of the obtained values of bending strength BS for particular research groups.
Fig. 4A diagram of the obtained values of mineralization degree BMD for particular research groups.
Fig. 5Histological slides of rat tibiae from particular groups, stained with hematoxylin and eosin. (Left picture – l; right picture – r) K group – l – periosteum, r – endosteum, note regular layers of bone from periosteal and endosteal side; TCDD group – l – diaphysis center, r – diaphysis endosteum, note the presence of the irregular in shape collagen fibers; LEV group – l – diaphysis periosteum, r – diaphysis center, note the centers of ossification in the diaphysis center; E and DEX groups – diaphysis periosteum, note the presence of arrest lines (arrow) from periosteum; ASA group – l – diaphysis periosteum, r – epiphysis, note the accelerate bone synthesis in the epiphysis; ASA + E group – l – diaphysis periosteum, r – epiphysis, arrest lines in diaphysis (arrow) and accelerate bone synthesis in epiphysis; mag. 200x.
Fig. 6Calcium to phosphorus ratio in the bones of the analyzed research groups. Scale bar represents standard deviation.
Composition of elements in the research groups under analysisa
| Ca [g kg−1] | P [g kg−1] | Mg [g kg−1] | Zn [mg kg−1] | Fe [mg kg−1 ] | |
|---|---|---|---|---|---|
| M ± SD | M ± SD | M ± SD | M ± SD | M ± SD | |
| K | 215.36 ± 5.99+ | 208.1 ± 5.80+ | 4.42 ± 0.11 | 127.08 ± 1.41+ | 18.15 ± 0.73+ |
| TCDD | 195.54 ± 3.07* | 215.9 ± 3.39* | 4.30 ± 0.01 | 142.45 ± 0.75* | 57.92 ± 1.17* |
| LEV | 235.62 ± 3.84*+ | 221.2 ± 3.61*+ | 4.74 ± 0.03*+ | 224.05 ± 4.03*+ | 43.99 ± 0.79* |
| E | 235.28 ± 3.69*+ | 228.0 ± 3.58*+ | 4.10 ± 0.03*+ | 143.08 ± 1.43* | 18.05 ± 0.17+ |
| DEX | 244.10 ± 2.42*+ | 204.1 ± 8.54+ | 4.05 ± 0.03*+ | 138.19 ± 0.63* | 22.78 ± 0.52+ |
| ASA | 210.69 ± 1.97*+ | 222.9 ± 2.08*+ | 4.57 ± 0.02*+ | 135.63 ± 1.88* | 30.49 ± 0.49*+ |
| ASA + E | 215.91 ± 7.20+ | 224.3 ± 6.02*+ | 4.20 ± 0.04* | 139.06 ± 1.03* | 22.46 ± 0.36+ |
M – mean; SD – standard deviation * – statistically significant difference at p < 0,05 to control group; + – statistically significant difference at p < 0,05 to TCDD group.